The risk factors for severe coronavirus disease 2019 (COVID-19) have been established on the basis of observational studies. However, the severe acute respiratory syndrome coronavirus
Read more
Wide-scale vaccine distribution is now taking place in the more economically developed countries worldwide, with counties such as the USA and UK having now vaccinated
Read more
The current coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has resulted in over 125 million cases and
Read more
Analysis indicated the number of mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD) doubles every 72 days. As the coronavirus
Read more
The deployed coronavirus disease 2019 (COVID-19) vaccines have been shown to provide robust immune responses for those administered. However, little investigation has taken place into
Read more
The results of a double-blind, randomized, multisite placebo-controlled trial that was conducted in South Africa show that Oxford’s ChAdOx1 nCoV-19 (AZD1222) vaccine has no efficacy
Read more
The machinery for viral replication and transcription is translated from particular sections of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome, open reading frames
Read more
In a methodologically trailblazing paper published in the journal Nature Genetics, a team of Belgian scientists uncovered an assembly of coronavirus host factors that may
Read more
The coronavirus disease 2019 (COVID-19) pandemic has already caused over 117.6 million confirmed cases the world over. Yet, researchers debate the exact incidence of reinfection
Read more
Since the start of the COVID-19 (coronavirus disease 2019) pandemic in late December 2019, the etiological agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of
Read more